Insights

Operations Brief · Healthcare & Life Sciences · 11 June 2026

A high denial rate costs your group more than any price rise could ever earn back.

A denial rate of 12-22% drains more than any price rise could earn. How to run denial reduction, credentialing and AR ageing as a discipline in the UAE.

The 30-second read

What a board member needs before the next meeting on this.

  1. Denial reduction beats a price rise. A denied claim is work already delivered and revenue already booked then handed back, so pulling denials from 12 to 22 percent toward a sub-5 percent benchmark recovers cash you have already paid to produce.
  2. Denials are a process failure, not bad luck. Run one quarter by reason code and a handful of causes drive most of the loss, repeating month after month because loose eligibility, coding and prior authorisation gaps go unowned.
  3. Credentialing is revenue infrastructure. A clinician not properly credentialed, or a lapsed facility contract, produces denials that look clinical and are entirely contractual; a pipeline running ahead of the rota closes that category before a claim is filed.
  4. AR ageing is a discipline, not a report. Money open at 120 days is close to a write-off, and working the ageing by bucket with real resubmission turns claims that would have aged out into collected revenue.
Applies to Owners of UAE groups carrying a denial rate they would rather not say out loud

The functions that decide whether a group keeps what it has earned rarely attract the founder's attention. They sit in the back office, carry none of the prestige of clinical growth or a new site, and get delegated early and inspected late. Yet the claims desk settles more of the margin question than the pricing sheet ever will.

01

THE MOST EXPENSIVE NUMBER YOU IGNORE

Ask a facility owner about margin and the conversation goes to pricing within a minute. Ask about the denial rate and you often get a shrug and a rough guess. That is backwards. A group denying 12 to 22 percent of its claims against a managed benchmark below five percent is losing more money at the claims desk than any price rise would ever recover on the floor. Every denied claim is work already delivered, cost already incurred, revenue already earned and then handed back. A price increase fights the payer for a few extra dirhams per line and invites scrutiny on the way. Denial reduction stops giving away revenue you have already booked and already paid to produce. One of those is a far larger prize, and it is the one most groups leave unmanaged because it lives in an administrative function nobody treats as strategic.

02

DENIALS ARE A PROCESS FAILURE, NOT BAD LUCK

High denial rates are not random and they are not the payer being difficult for its own sake. They are the visible output of upstream process gaps. Eligibility checked loosely at the front desk. Coding that does not match the clinical documentation. Prior authorisation missed or logged after the fact. A submission that trips a payer rule someone should have known and coded around. Each denial traces back to a specific point where the process let it through, and that point can be found. Run the denials by reason code for one quarter and the pattern is rarely subtle. A handful of causes drive most of the loss, and they repeat month after month because nobody owns them end to end. Treating denials as bad luck guarantees they keep coming. Treating them as a process to be engineered is what pulls the rate down and, more importantly, holds it down.

03

CREDENTIALING IS REVENUE INFRASTRUCTURE

Payer credentialing sits underneath all of this and rarely gets the attention it earns. When a clinician is not properly credentialed with a payer, or a facility contract has lapsed or drifted from its original terms, claims are denied for reasons that have nothing to do with the care delivered. New doctors billing before their paperwork clears. Contracts renewed on terms no one modelled against actual case mix. This is not administrative housekeeping to be done when someone finds time. It is revenue infrastructure, and when it is weak it produces a steady stream of denials that look clinical and are entirely contractual. A credentialing pipeline that runs ahead of the clinical rota, rather than chasing it after a doctor has already started seeing patients, closes off a whole category of loss before a single claim is submitted.

04

AR AGEING IS A DISCIPLINE, NOT A REPORT

The other half of the discipline is the ageing of your receivables. Money owed at 30 days is a collection task. Money still open at 120 days is close to a write-off, and every UAE facility carries a bucket of it that quietly grows. Working the AR ageing as a standing routine, with clear ownership by bucket and a resubmission process that actually turns rejections back into paid claims, is what converts booked revenue into cash in the account. Most groups run this reactively, chasing the largest balances only when cash gets tight and ignoring the rest until it ages out. Run as a discipline, the ageing profile itself becomes shorter over time, write-offs fall, and cash arrives sooner and more predictably, which changes how the whole business can be planned. A resubmission that used to sit untouched for weeks gets worked while the payer window is still open, and the claims that would once have aged into a write-off come back as collected revenue instead of a note in the year-end accounts.

05

REVENUE CYCLE RUN LIKE AN OPERATION

06

THE DENIAL RATE SHOWS UP IN THE BANK BALANCE

Profit is an accounting opinion and cash is a fact, and the denial rate is where the two come apart. Every claim queried, partially rejected and resubmitted under DHA and DOH mandatory insurance is revenue you have booked and cannot spend, sitting in the ageing while the cost of delivering the work has already left the account. That is why a group can be more profitable this year than last and hold less cash, simply because the cycle lengthened. An AR ageing drifting from 60 to 90 days and beyond is the denial rate expressed in dirhams, and it is why owners with healthy margins spend the last week of the month finding money for payroll. The disciplines that pull the rate down are the same ones that shorten the cycle. Clean first-submission coding, fast resubmission, and a hard read on which payers settle on time and which you are effectively financing for free. Every day stripped out of the ageing is cash back in the business without borrowing a dirham.

07

ARRANGE THE HEADROOM BEFORE YOU NEED IT

A group carrying a denial rate it cannot yet control needs a deliberate buffer between the cash it holds and the cash it could suddenly need. Headroom is what absorbs a payer delay, a slow quarter, or the working capital drawn in by opening a new site, without forcing a distressed decision. The instruments exist. A receivables or invoice financing facility that turns approved insurance claims into cash sooner, an overdraft sized to the real swing in your cycle, a term facility matched to capital expenditure rather than funded from operating cash. Arrange all of it from a position of strength, rather than negotiating with a lender in the week the account runs dry, because facilities agreed under pressure carry worse terms and lenders read desperation as clearly as an analyst reads a soft model. The cheaper source is still the cycle itself. Pulling thirty days out of receivables can release more cash than a financing round, at no cost and no dilution, and it starts at the claims desk.

Before your next meeting

Questions for your next revenue-cycle review

  1. What is our denial rate this quarter by reason code, and who owns the top three causes?
  2. Are new clinicians billing before their payer credentialing has cleared?
  3. How much revenue sits in our 90 and 120-day AR buckets, and who works it before the payer window closes?
  4. Do we run revenue cycle to a target, or react only when cash gets tight?

Avior builds and runs the full cycle as one operation. Eligibility, coding, submission, denial management, credentialing and AR ageing held to a target rather than left to react, with the impact measured in your collected revenue rather than described in a report. Our incentives are set to move with the cash we help you recover. If your denial rate is a number you would rather not say out loud, bring it to Avior and we will bring it down.

Start a conversationMore insights

Engagement · Limited mandates

Choosing who advises you is itself a strategic decision.

We take a limited number of mandates at any time. If you are working a decision that needs independent counsel, start with a conversation.